Main Session
Sep
28
SS 04 - GYN 1: Molecular and Precision Medicine for gynecologic cancers in diverse resource settings
121 - Impact of MMR Status vs. Clinicopathologic Risk Factors on Locoregional Recurrence in Stage I Endometrioid Endometrial Cancer Treated with Brachytherapy Alone
Presenter(s)
Lara Hathout, MD, FRCPC - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ